Jazz Pharmaceuticals PLC at Jefferies Healthcare Conference Transcript
All righty. Good afternoon, everyone. I hope you're all enjoying the conference so far. It's really good to be back in person, I will tell you that much.
My name is Akash Tewari. I'm a biotech analyst here at Jefferies. I have the pleasure of hosting the Jazz management team today.
Joining us is Renee Gala, CFO; John Miller, Global Product Strategy and Program Management Head; Dan Swisher, President of Jazz; and then Josh Steinerman, VP of Neuropsychiatry. Thanks so much for joining us.
Maybe, Renee, do you want me to give it to you for some introductory remarks, and then we can get into any specific questions?
Sure. That's sounds great. So thank you for having us. It's a pleasure to be here and super exciting to be in person as well.
So just before we get started though, I'll remind you all, we will be making forward-looking statements today. Please consult our website for our SEC filings and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |